Anagram Therapeutics
Anagram Therapeutics Inc.
- UEI
- GGVLW5K25NB6
- CAGE
- 8KL73
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A novel highly stable pancreatic enzyme replacement therapy to improve outcomes for patients with pancreatic… | National Institute of Diabetes and Digestive and Kidney Diseases | $3,593,286 |
Quick answers
What is Anagram Therapeutics's UEI?
Anagram Therapeutics's Unique Entity ID (UEI) in SAM.gov is GGVLW5K25NB6.
What is Anagram Therapeutics's CAGE code?
Anagram Therapeutics's CAGE code is 8KL73.
Is Anagram Therapeutics registered in SAM.gov?
Anagram Therapeutics's SAM.gov registration expired on October 2, 2024.
What is Anagram Therapeutics's most recent federal award?
Anagram Therapeutics's most recent federal grant award is A novel highly stable pancreatic enzyme replacement therapy to improve outcomes for patients with pancreatic… (R44DK134212), from National Institute of Diabetes and Digestive and Kidney Diseases, on August 5, 2022.
On GovTribe
See Anagram Therapeutics's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors